These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33540336)

  • 1. Efficacy and Safety of the Telestroke Drip-And-Stay Model: A Systematic Review and Meta-Analysis.
    Waseem H; Salih YA; Burney CP; Abel MA; Riblet N; Kim A; Robbins N
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105638. PubMed ID: 33540336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Stroke Outcomes of Hub and Spoke Hospital Treated Patients in Mayo Clinic Telestroke Program.
    Demaerschalk BM; Boyd EL; Barrett KM; Gamble DM; Sonchik S; Comer MM; Wieser J; Hentz JG; Fitz-Patrick D; Chang YH
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2940-2942. PubMed ID: 30146388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Functional Outcome of Telestroke Patients Treated Under Drip-and-Stay Paradigm Compared with Patients Treated in a Comprehensive Stroke Center: A Single Center Experience.
    Almallouhi E; Holmstedt CA; Harvey J; Reardon C; Guerrero WR; Debenham E; Turner N; Aysse P; Al Kasab S
    Telemed J E Health; 2019 Aug; 25(8):724-729. PubMed ID: 30256734
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.
    You S; Saxena A; Wang X; Tan W; Han Q; Cao Y; Liu CF
    Stroke Vasc Neurol; 2018 Mar; 3(1):22-27. PubMed ID: 29600004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes Among Patients With Ischemic Stroke Treated With Intravenous tPA (Tissue-Type Plasminogen Activator) via Telemedicine.
    Wysocki NA; Bambhroliya A; Ankrom C; Vahidy F; Astudillo C; Trevino A; Malazarte R; Cossey TC; Jagolino-Cole A; Savitz S; Wu TC; Sharrief A
    Stroke; 2019 Apr; 50(4):895-900. PubMed ID: 30852962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Spoke-Retained Telestroke Patients Versus Hub-Treated Patients After Intravenous Thrombolysis: Telestroke Patient Outcomes After Thrombolysis.
    Heffner DL; Thirumala PD; Pokharna P; Chang YF; Wechsler L
    Stroke; 2015 Nov; 46(11):3161-7. PubMed ID: 26396027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the Drip-and-Ship Paradigm for Patients with Acute Ischemic Stroke in South Korea.
    Park MS; Lee JS; Park TH; Cho YJ; Hong KS; Park JM; Kang K; Lee KB; Kim JG; Lee SJ; Lee J; Choi KH; Kim JT; Cho KH; Oh MS; Yu KH; Lee BC; Cha JK; Kim DH; Nah HW; Lee J; Kim DE; Ryu WS; Kim BJ; Han MK; Bae HJ; Song SK; Choi JC
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2678-2687. PubMed ID: 27480820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe.
    Pervez MA; Silva G; Masrur S; Betensky RA; Furie KL; Hidalgo R; Lima F; Rosenthal ES; Rost N; Viswanathan A; Schwamm LH
    Stroke; 2010 Jan; 41(1):e18-24. PubMed ID: 19910552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: A systematic review and meta-analysis of safety and efficacy.
    Abbas A; Hamad AA; El Din Moawad MH; Ewis DK; Youssef RA; Hamouda H; Hassan MA; Aladawi M; Elfil M; Meshref M; Al-Mufti F
    J Stroke Cerebrovasc Dis; 2024 Jul; 33(7):107704. PubMed ID: 38561167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.
    Wang X; You S; Sato S; Yang J; Carcel C; Zheng D; Yoshimura S; Anderson CS; Sandset EC; Robinson T; Chalmers J; Sharma VK
    Stroke Vasc Neurol; 2018 Mar; 3(1):28-33. PubMed ID: 29600005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of thrombolysis in telestroke: A systematic review and meta-analysis.
    Kepplinger J; Barlinn K; Deckert S; Scheibe M; Bodechtel U; Schmitt J
    Neurology; 2016 Sep; 87(13):1344-51. PubMed ID: 27566746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.
    Liu H; Zheng H; Cao Y; Pan Y; Wang D; Zhang R; You S; Zhang X; Li S; Tong X; Liu CF; Wang Y
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):988-997. PubMed ID: 29224744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of Symptomatic Intracerebral Hemorrhage Related to Intravenous tPA Administered Over Telestroke Within 4.5-Hour Window.
    Al Kasab S; Orabi MY; Harvey JB; Turner N; Aysse P; Debenham E; Holmstedt CA
    Telemed J E Health; 2018 Oct; 24(10):749-752. PubMed ID: 29369743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
    Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote Longitudinal Inpatient Acute Stroke Care Via Telestroke.
    Sobhani F; Desai S; Madill E; Starr M; Rocha M; Molyneaux B; Jovin T; Wechsler L; Jadhav A
    J Stroke Cerebrovasc Dis; 2021 Jun; 30(6):105749. PubMed ID: 33784522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
    Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
    Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of thrombolytic therapy in acute ischemic stroke: mothership, drip-and-ship, and ship-and-drip paradigms.
    Kijpaisalratana N; Chutinet A; Akarathanawat W; Vongvasinkul P; Suwanwela NC
    BMC Neurol; 2020 Feb; 20(1):45. PubMed ID: 32013906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S; Liang L; Kosinski A; Hernandez AF; Schwamm LH; Smith EE; Fonarow GC; Bhatt DL; Feng W; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e006031. PubMed ID: 31903770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.